ANTI-DRUG ANTIBODIES (ADAS)

Clinical trials for ANTI-DRUG ANTIBODIES (ADAS) explained in plain language.

Never miss a new study

Get alerted when new ANTI-DRUG ANTIBODIES (ADAS) trials appear

Sign up with your email to follow new studies for ANTI-DRUG ANTIBODIES (ADAS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New eye injection trial seeks to control Diabetes-Related vision loss

Disease control Not yet recruiting

This early-stage study aims to check the safety of a new eye injection called PRO-169 for people with diabetic macular edema, a condition that causes vision loss. The main goal is to see if the body's immune system reacts to the drug by measuring antibodies in the blood. The stud…

Matched conditions: ANTI-DRUG ANTIBODIES (ADAS)

Phase: PHASE1 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

ANTI-DRUG ANTIBODIES (ADAS)

Get alerted when new ANTI-DRUG ANTIBODIES (ADAS) trials appear

New eye injection trial seeks to control Diabetes-Related vision loss